紧急用聚四乙烯覆盖的支架植入用于治疗冠状动脉破裂
C Briguori1, T Nishida, A Anzuini
1Centro Cuore Columbus, Milan, Italy.
Circulation
|January 11, 2000
概括
覆盖着聚四乙烯 (PTFE) 的支架在保守方法失败时有效治疗冠状动脉穿孔. 这种方法显著减少了紧急手术和不良事件,为血管破裂提供了可行的非手术选择.
科学领域:
- 干预心脏病学 干预心脏病学
- 血管外科 血管外科
- 生物材料科学 生物材料科学
背景情况:
- 冠状动脉穿孔是皮肤间干预过程中的严重并发症.
- 冠状动脉穿孔的传统治疗方法包括长时间的气球膨胀和抗凝逆转.
- 覆盖式支架植入是耐火冠状动脉穿孔的新兴策略.
研究的目的:
- 评估聚四乙烯 (PTFE) 覆盖的支架在治疗冠状动脉穿孔方面的有效性和安全性.
- 为了比较PTFE覆盖的支架治疗结果与冠状动脉破裂的非覆盖支架的结果.
主要方法:
- 以PTFE覆盖的支架 (PTFE组) 与未覆盖的支架 (非PTFE组) 进行治疗的冠状动脉破裂患者的回顾性分析.
- 12个PTFE覆盖的支架植入了11名耐火冠状动脉穿孔的患者.
- 结果进行了比较,包括成功密封,需要紧急手术和临床事件.
主要成果:
- 所有12个用PTFE覆盖的支架治疗的血管破裂都成功密封了.
- 与非PTFE组相比,PTFE组的心脏吸管和急诊手术的发生率明显较低.
- 在使用PTFE覆盖支架治疗的11名患者中,10名患者的早期临床结果是最佳的,在随访时没有发生重大心脏不良事件.
结论:
- 用PTFE覆盖的支架植入是一种安全有效的冠状动脉破裂的非手术治疗方法.
- 这一策略为治疗复杂冠状动脉穿孔的手术提供了有价值的替代方案.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
01:30Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
01:28Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522